Form 4: Emergent BioSolutions Director Kathryn C. Zoon Sells Shares
SEC Form 4 Filing
Director Kathryn C. Zoon sold 1,830 shares of Emergent BioSolutions Inc. (EBS) common stock at a price of $4.61 per share on May 29, 2024, according to a Form 4 filing with the SEC.
Summary
- Kathryn C. Zoon, a director of Emergent BioSolutions Inc., reported a transaction involving the sale of company stock.
- On May 29, 2024, Ms. Zoon sold 1,830 shares of common stock at a price of $4.61 per share.
- Following the transaction, Ms. Zoon beneficially owns 64,482 shares of Emergent BioSolutions Inc.
- The sale was executed under a pre-existing trading plan adopted on June 15, 2022.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This transaction is a routine disclosure of insider trading activity. It's common for directors and officers to have pre-arranged trading plans to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| June 15, 2022 | Date Ms. Zoon adopted the trading plan. |
| May 29, 2024 | Date of the stock sale transaction. |
| May 31, 2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.